HappeningToo topic
Dabigatran Etexilate Mesylate reports
Browse community reports connected to Dabigatran Etexilate Mesylate. These reports can show that other people are describing similar experiences, but they do not prove that Dabigatran Etexilate Mesylate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
28 problems
Abdominal Discomfort while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and abdominal discomfort appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and abdominal pain upper appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and abdominal pain appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and acid reflux appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and back pain appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and chest discomfort appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and constipation appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and cough appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and decreased appetite appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and diarrhea appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and dizziness appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and dyspepsia appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and fatigue appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and feeling abnormal appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and flatulence appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and headache appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and hypotension appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and insomnia appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and itching appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and malaise appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and nausea appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and pain appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and peripheral swelling appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and rash appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and shortness of breath appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and vomiting appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and weakness appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Dabigatran Etexilate Mesylate
FDA FAERS contains adverse-event reports in which Dabigatran Etexilate Mesylate and weight decreased appear together. This does not establish that Dabigatran Etexilate Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →